MR Spectroscopy of the Fetal Brain: Is It Possible without Sedation?

References

1. 1.↵
   1. Pugash D,
   2. Krssak M,
   3. Kulemann V,
   4. et al

   . Magnetic resonance spectroscopy of the fetal brain. Prenat Diagn 2009;29:434–41

   CrossRefPubMed
2. 2.↵
   1. Huppi PS,
   2. Amato M

   . Advanced magnetic resonance imaging techniques in perinatal brain injury. Biol Neonate 2001;80:7–14

   PubMed
3. 3.↵
   1. Toft PB,
   2. Leth H,
   3. Lou HC,
   4. et al

   . Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J Magn Reson Imaging 1994;4:674–80

   PubMedWeb of Science
4. 4.↵
   1. Cady EB,
   2. Amess P,
   3. Penrice J,
   4. et al

   . Early cerebral-metabolite quantification in perinatal hypoxic-ischaemic encephalopathy by proton and phosphorus magnetic resonance spectroscopy. Magn Reson Imaging 1997;15:605–11

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Girard N,
   2. Gouny SC,
   3. Viola A,
   4. et al

   . Assessment of normal fetal brain maturation in utero by proton magnetic resonance spectroscopy. Magn Reson Med 2006;56:768–75

   CrossRefPubMed
6. 6.↵
   1. Kok RD,
   2. Steegers-Theunissen RP,
   3. Eskes TK,
   4. et al

   . Decreased relative brain tissue levels of inositol in fetal hydrocephalus. Am J Obstet Gynecol 2003;188:978–80

   CrossRefPubMed
7. 7.↵
   1. Azpurua H,
   2. Alvarado A,
   3. Mayobre F,
   4. et al

   . Metabolic assessment of the brain using proton magnetic resonance spectroscopy in a growth-restricted human fetus: case report. Am J Perinatol 2008;25:305–09

   CrossRefPubMed
8. 8.↵
   1. Astley SJ,
   2. Richards T,
   3. Aylward EH,
   4. et al

   . Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders. Magn Reson Imaging 2009;27:760–78

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Roelants-van Rijn AM,
   2. Groenendaal F,
   3. Stoutenbeek P,
   4. et al

   . Lactate in the foetal brain: detection and implications. Acta Paediatr 2004;93:937–40

   CrossRefPubMed
10. 10.↵
    1. Roelants-Van Rijn AM,
    2. van der Grond J,
    3. de Vries LS,
    4. et al

    . Value of ¹H-MRS using different echo times in neonates with cerebral hypoxia-ischemia. Pediatr Res 2001;49:356–62

    PubMedWeb of Science
11. 11.↵
    1. Brunel H,
    2. Girard N,
    3. Confort-Gouny S,
    4. et al

    . Fetal brain injury. J Neuroradiol 2004;31:123–37

    CrossRefPubMed
12. 12.↵
    1. Gerards FA,
    2. Stoutenbeek P,
    3. Gooskens RH,
    4. et al

    . Diagnostic value of prenatal MRI in fetus with intracranial anomalies diagnosed by ultrasonography [in Dutch]. Ned Tijdschr Geneeskd 2001;145:179–84

    PubMed
13. 13.↵
    1. Kostović I,
    2. Judas M,
    3. Rados M,
    4. et al

    . Laminar organization of the human fetal cerebrum revealed by histochemical markers and magnetic resonance imaging. Cereb Cortex 2002;12:536–44

    Abstract/FREE Full Text
14. 14.↵
    1. Kasprian G,
    2. Brugger PC,
    3. Weber M,
    4. et al

    . In utero tractography of fetal white matter development. Neuroimage 2008;43:213–24

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Kanto J,
    2. Erkkola R,
    3. Kangas L,
    4. et al

    . Placental transfer of flunitrazepam following intramuscular administration during labour. Br J Clin Pharmacol 1987;23:491–94

    CrossRefPubMed
16. 16.↵
    1. Oelschläger H

    . Chemical and pharmacologic aspects of benzodiazepines [in German]. Schweiz Rundsch Med Prax 1989:78:766–72

    PubMed
17. 17.↵
    1. Kanto JH

    . Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs 1982:23:354–80

    PubMedWeb of Science
18. 18.↵
    1. Hindmarch I

    . A repeated dose comparison of three benzodiazepine derivative (nitrazepam, flurazepam and flunitrazepam) on subjective appraisals of sleep and measures of psychomotor performance the morning following night-time medication. Acta Psychiatr Scand 1977:56: 373–81

    PubMed
19. 19.↵
    1. Prayer D,
    2. Kasprian G,
    3. Krampl E,
    4. et al

    . MRI of normal fetal brain development. Eur J Radiol 2006;57:199–216

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Legido A,
    2. Valencia I,
    3. Smith JD

    . Fetal neurological evaluation [in Spanish]. Rev Neurol 2004:15;39:454–64
21. 21.↵
    1. Counsell SJ,
    2. Maalouf EF,
    3. Fletcher AM,
    4. et al

    . MR imaging assessment of myelination in the very preterm brain. AJNR Am J Neuroradiol 2002;23:872–81

    Abstract/FREE Full Text
22. 22.↵
    1. Huang H,
    2. Zhang J,
    3. Wakana S,
    4. et al

    . White and gray matter development in human fetal, newborn and pediatric brains. Neuroimage 2006:15;33:27–38
23. 23.↵
    1. Madhavarao CN,
    2. Hammer JA,
    3. Quarles RH,
    4. et al

    . A radiometric assay for aspartoacylase activity in cultured oligodendrocytes. Anal Biochem 2002;308:314–19

    CrossRefPubMed
24. 24.↵
    1. Kirmani BF,
    2. Jacobowitz DM,
    3. Namboodiri MA

    . Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination. Brain Res Dev Brain Res 2003;140:105–15

    PubMed
25. 25.↵
    1. Kato T,
    2. Nishina M,
    3. Matsushita K,
    4. et al

    . Neuronal maturation and N-acetyl-L-aspartic acid development in human fetal and child brains. Brain Dev 1997;19:131–33

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Kok RD,
    2. van den Berg PP,
    3. van den Bergh AJ,
    4. et al

    . Maturation of the human fetal brain as observed by 1H MR spectroscopy. Magn Reson Med 2002;48:611–16

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Girard N,
    2. Fogliarini C,
    3. Viola A,
    4. et al

    . MRS of normal and impaired fetal brain development. Eur J Radiol 2006;57:217–25

    CrossRefPubMed
28. 28.↵
    1. Heerschap A,
    2. Kok RD,
    3. van den Berg PP

    . Antenatal proton MR spectroscopy of the human brain in vivo. Childs Nerv Syst 2003;19:418–21

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Kreis R,
    2. Hofmann L,
    3. Kuhlmann B,
    4. et al

    . Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002;48:949–58

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Story L,
    2. Damodaram MS,
    3. Allsop JM,
    4. et al

    . Brain metabolism in fetal intrauterine growth restriction: a proton magnetic resonance spectroscopy study. Am J Obstet Gynecol 2011;205:483.e1–8

    CrossRefPubMed
31. 31.↵
    1. Charles-Edwards GD,
    2. Jan W,
    3. To M,
    4. et al

    . Non-invasive detection and quantification of human foetal brain lactate in utero by magnetic resonance spectroscopy. Prenat Diagn 2010;30:260–66

    PubMed
32. 32.↵
    1. Wolfberg AJ,
    2. Robinson JN,
    3. Mulkern R,
    4. et al

    . Identification of cerebral lactate using magnetic resonance spectroscopy. Am J Obstet Gynecol 2007;196:e9–11

    PubMed
33. 33.↵
    1. Moxon-Lester L,
    2. Sinclair K,
    3. Burke C,
    4. et al

    . Increased cerebral lactate during hypoxia may be neuroprotective in newborn piglets with intrauterine growth restriction. Brain Res 2007;1179:79–88

    CrossRefPubMed
34. 34.↵
    1. Taberno A,
    2. Vicario C,
    3. Medina JM

    . Lactate spares glucose as a metabolic fuel in neurons and astrocytes from primary culture. Neurosci Res1996;26:369–76

    CrossRefPubMedWeb of Science